Contralateral Eye Myopic Prk Comparison Of Use In One Eye Adjunct Amniotic Solution
Published 2024 - 42nd Congress of the ESCRS
Reference: PO1263 | Type: Poster | DOI: 10.82333/0j2m-tn97
Authors: Anastasios John Kanellopoulos* 1 , Alexandros John Kanellopoulos 2
1Ophthalmology,LaserVision Ambulatory Eye Surgery Unit,Athens,Greece;Ophthalmology,NYU Med School,New York,United States, 2Ophthalmology,LaserVision Ambulatory Eye Surgery Unit,Athens,Greece
Purpose
To investigate safety, efficacy and stability of amniotic solution used after PRK
Setting
The Laservision Clinical and Research Institute, Athens, Greece
Methods
This contralateral eye, consecutive case series study included 50 eyes of 25 patients who have undergone bilateral myopic PRK with mechanical epithelial removal , in which one eye (group-A) was treated with PRK and adjunct amniotic solution, while the other eye (group-B) with PRK and contact lens alone. Besides the subjective pain score, visual acuity, corneal keratometry, astigmatism, epithelial distribution and minimum corneal thickness were evaluated at the first postoperative day, the day of complete re-epithelization for each eye, 1, 3 and 6 months postoperatively.
Results
Mean Values: Pain score group a 0.5 (1-4) while group B 1 (P<0.02), Epithelization; day 5 vs. day 7 respectively. The tomographic and visual function data were comparable between the 2 groups.
Conclusions
The adjunct amniotic solution used in PRK may accelerate re-epithelization, improve first day pain profile and also improve epithelial remodeling within the first postoperative month.